The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 25,001–25,100 of 31,469
Insulin resistance and adaptation of pancreatic beta cells during pregnancy
Zielińska-Maciulewska, A., Kretowski, A. J., & Szelachowska, M. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0022 · Cited by 4
Huang, J., Fukuo, K., Yoshino, G., et al. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621153 · Cited by 4
Sawczyn, T., Stygar, D. M., Nabrdalik, K., Kukla, M., Skrzep-Poloczek, B., Wesołowski, B., Olszańska, E., Dulska, A., Gumprecht, J., Karcz, W. K., et al. (2019) · Peptides · doi:10.1016/j.peptides.2019.04.001 · Cited by 4
Diyet Kalitesi ve Sedanter Geçirilen Süre Obez Fenotiplerinde Metabolik Sağlığı Etkiler mi?
Bilgiç, P., & Öteleş, S. (2019) · Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.21020/husbfd.541591 · Cited by 4
Ngueta, G. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01390-x · Cited by 4
Concon, M. M., Jimenez, L. S., Callejas, G. H., Chaim, É. A., & Cazzo, E. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.08.023 · Cited by 4
Tanvig, M. H., Jensen, D. M., Andersen, M., et al. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13722 · Cited by 4
Eroğlu, S., ÇAKMAKLIOĞULLARI, M., & Çakmaklıoğulları, E. K. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1634026 · Cited by 4
Стаценко, М. Е., Туркина, С. В., Kosivtsova, M. A., et al. (2019) · Journal of Volgograd State Medical University · doi:10.19163/1994-9480-2019-2(70)-134-139 · Cited by 4
Bozzetto, L., Berntzen, B. J., Kaprio, J. A., Rissanen, A., Taskinen, M., & Pietiläinen, K. H. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.10.005 · Cited by 4
Ibrahim, S. M., & Bastawy, A. A. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666191210122851 · Cited by 4
Batista, A. P., Barbosa, K. F., Masioli, C. Z., et al. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209113 · Cited by 4
Marinho, A., Severo, M., Ramos, E., & Lopes, C. M. M. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.03.001 · Cited by 4
Evaluation of Serum Clusterin Levels in Type 2 Diabetic Men with and without Cardiovascular Disease
Fayez, S. S., Rashied, R. M., & Alaaraji, S. F. T. (2020) · Iraqi Journal of Science · doi:10.24996/ijs.2020.61.5.5 · Cited by 4
Mallinson, P. A. C., Lieber, J., Bhogadi, S., et al. (2020) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2020-214016 · Cited by 4
Nolin, M.-A., Demers, M., Rauzier, C., Bouchard, R., Cadrin, C., Despres, J., Roy, M., Alméras, N., & Picard, F. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1770858 · Cited by 4
Assessing insulin sensitivity and resistance in syndromes of severe short stature
Guevara‐Aguirre, J., Terán, E., Lescano, D., Guevara, C., Guevara, A., Saavedra, J., Prócel, P., Wasserfall, C. H., & Gavilanes, A. W. D. (2020) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2020.101339 · Cited by 5
Marín-Echeverri, C., Piedrahita-Blandón, M., Galvis-Pérez, Y., Núñez-Rangel, V., Blesso, C. N., Fernández, M. L., & Barona-Acevedo, J. (2020) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-8-8-3 · Cited by 4
Aggan, H. E., Mahmoud, S., Shair, H. E., & Elabd, H. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.09.004 · Cited by 4
Primo, D., Izaola, O., & de Luis, D. A. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.09.002 · Cited by 4
Lv, Q., Zhou, J., Liu, J., Kang, D., & Zhang, H. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0186 · Cited by 4
Amadi, J. A., Amadi, P. U., Njoku, U. C., & Onitchi, C. L. (2021) · PubMed Central · doi:10.22038/ijbms.2020.49770.11368 · Cited by 6
de Lima, T. R., González‐Chica, D. A., Moreno, Y. M. F., & Silva, D. A. S. (2020) · The Physician and Sportsmedicine · doi:10.1080/00913847.2020.1862633 · Cited by 4
Effects of rapid growth on fasting insulin and insulin resistance: a system review and meta-analysis
Ma, D., Chen, Z., Wang, Y., Yu, X., Xin, Q., & Chen, Y. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00831-z · Cited by 4
Yamauchi, M., Tsuchiya, T., Takebayashi, K., et al. (2021) · Diabetology International · doi:10.1007/s13340-020-00485-z · Cited by 4
Ding, L., Wang, B.-P., Chen, T.-T., Li, P., Guo, W., Fan, Y.-X., Fang, F., Cui, J., Dong, Z.-L., He, Q., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01126-7 · Cited by 2
Lee, J., Park, W., Sung, E.-S., Kim, B., Kim, N.-H., Park, S., Shin, C., & Park, J. (2020) · Physical Activity and Nutrition · doi:10.20463/pan.2020.0026 · Cited by 4
Tabaei, B. S., Mousavi, S. N., Rahimian, A., et al. (2022) · PubMed · doi:10.30476/ijms.2021.89102.1981 · Cited by 4
Mahdavifard, S., Dehghani, R., Jeddi, F., & Najafzadeh, N. (2021) · PubMed Central · doi:10.22038/ijbms.2021.53707.12086 · Cited by 6
Rondanelli, M., Peroni, G., Giacosa, A., Fazia, T., Bernardinelli, L., Naso, M., Faliva, M. A., Tartara, A., Gasparri, C., & Perna, S. (2021) · Nutrients · doi:10.3390/nu13020439 · Cited by 4
Longitudinal association between leisure-time physical activity and vascular elasticity indices
Szaló, G., Hellgren, M. I., Allison, M., Råstam, L., Lindblad, U., & Daka, B. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01911-z · Cited by 8
de Luis, D. A., Martín, D. P., & Izaola, O. (2021) · Nutrición Hospitalaria · doi:10.20960/nh.03423 · Cited by 4
Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy
Mastorakos, G. P., Maliopoulos, D., Kasioni, S., Bargiota, Α., Barber, T. M., Skevaki, C. L., Papassotiriou, I., Vrachnis, N., Farmakides, G., Vlahos, N., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab152 · Cited by 4
Htwe, T. N., Thein, O. M., Hmone, S. W., & Thandar, M. (2021) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.036.01.03 · Cited by 4
Miyazato, M., Ashikari, A., Nakamura, K., et al. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02867-x · Cited by 4
Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region
GÜNGÖR, N. D., ÇELİK, S., GÜÇLÜ, M., ÇELİK, S., & Cengiz, F. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.3.5 · Cited by 4
Tilves, C., Zmuda, J. M., Kuipers, A. L., Nair, S., Carr, J., Terry, J., Peddada, S., Wheeler, V. W., & Miljkovic, I. (2021) · Obesity Science & Practice · doi:10.1002/osp4.529 · Cited by 2
Insulin-Like Growth Factor-II and Ischemic Stroke—A Prospective Observational Study
Åberg, D., Åberg, N. D., Jood, K., Redfors, P., Blomstrand, C., Isgaard, J., Jern, C., & Svensson, J. (2021) · Life · doi:10.3390/life11060499 · Cited by 4
Kalahasthi, R., Jakkam, S., Prakash, J. R., & Adepu, V. K. (2021) · Asian Biomedicine · doi:10.2478/abm-2021-0009 · Cited by 4
Vitamin D as a biomarker of health in snoring children: a familial aggregation study
Barceló, A., Morell‐García, D., Ribot, C., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01612-5 · Cited by 4
Thomsen, C. F., Goharian, T. S., Larsen, K. T., Goetze, J. P., Andersen, L. B., & Jeppesen, J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020676 · Cited by 4
Sato, Y., Isojima, T., 聖実, 高., et al. (2021) · Hormone Research in Paediatrics · doi:10.1159/000518617 · Cited by 4
Borges, J. H., de Oliveira, D. M., de Lemos‐Marini, S. H. V., Geloneze, B., Guerra‐Júnior, G., & Gonçalves, E. M. (2021) · Osteoporosis International · doi:10.1007/s00198-021-06097-w · Cited by 4
Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism
Maraninchi, M., Calabrese, A., Nogueira, J. P., Castinetti, F., Mancini, J., Mourre, F., Pietri, L., Benamo, E., Albarel, F., Morange, I., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.08.003 · Cited by 4
He, W., Wang, L., Zhang, Y., Jiang, Y., Chen, X., Wang, Y., Dou, Y., Chen, H., & Yan, W. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.701422 · Cited by 4
Akwo, E. A., Sahinoz, M., Alsouqi, A., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.08.031 · Cited by 4
González‐Gil, E. M., Giménez-Legarre, N., Cardon, G., Mavrogianni, C., Kivelä, J., Iotova, V., Tankova, T. I., Rurik, I., Liatis, S., Makrilakis, K., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04449-0 · Cited by 5
Wu, A., Li, Y., Liu, R., Qi, D., Yu, G., Yan, X.-J., Mao, D., Li, X., Zhou, R., & Dai, W.-M. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1648-7767 · Cited by 4
Relationship Between Interleukin 33 and Tissue Factor in Non-Diabetic and Diabetic Obese Patients
Çakici, Ç., Yiğitbaşı, T., Alagoz, M. H., Yi̇ği̇t, P., & Emekli, N. (2021) · ACTA Pharmaceutica Sciencia · doi:10.23893/1307-2080.aps.05934 · Cited by 4
Balcázar‐Hernández, L., Basurto, L., Apolinar, L. M., Vega-García, S., Basurto-Acevedo, N. E., Murillo, C. M., & Sánchez‐Arenas, R. (2021) · Metabolites · doi:10.3390/metabo11110771 · Cited by 4
Jensterle, M., Kravos, N. A., Dolžan, V., Goričar, K., Herman, R., Rizzo, M., & Janež, A. (2021) · Endocrine · doi:10.1007/s12020-021-02934-4 · Cited by 4
SCARINCI, E., NOTARISTEFANO, G., TROPEA, A., FABOZZI, S. M., ALESIANI, O., MEUCCI, E., SILVESTRINI, A., Cintoni, M., Diterlizzi, A., LANZONE, A., et al. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04983-6 · Cited by 4
Methods for Quantifying Insulin Sensitivity and Determining Insulin Time-Action Profiles
Krentz, A. J., Heinemann, L., & Hompesch, M. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4920-0_1 · Cited by 5
Albeltagy, E. S., & Elbaky, N. M. A. (2021) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2021.200137 · Cited by 4
Adipocyte related peptides — galanin and resistin in endometrioid type endometrium cancer
Avcıoğlu, S. N., & Yüksel, H. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0229 · Cited by 4
Study of changes in biochemical parameters of preeclampsia patients, a prospective five year study
Saha, A., & Gupta, A. D. (2022) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20220181 · Cited by 4
Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?
Leal, K. M., Rocha, M. B., Varela, F. V., Rodrigues, L., Furtado, P. V., da Costa, F. V. A., & Pöppl, Á. G. (2022) · Topics in companion animal medicine · doi:10.1016/j.tcam.2022.100648 · Cited by 4
Benkov, A. A., Nagornev, S. N., Frolkov, V. K., et al. (2022) · European Journal of Translational Myology · doi:10.4081/ejtm.2022.10351 · Cited by 4
Cai, H., Jin, S., Lin, J.-F., Yu, L., Xu, J., Qian, P., & Chen, W. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15141 · Cited by 4
Ottarsdottir, K., Tivesten, Å., Li, Y., Lindblad, U., Hellgren, M. I., Ohlsson, C., & Daka, B. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac050 · Cited by 5
Cao, W., Xu, Y., Shen, Y., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.03.027 · Cited by 4
HINDSØ, M. G., Bojsen-Møller, K. N., Kristiansen, V. B., Holst, J. J., van Hall, G., & Madsbad, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01123-1 · Cited by 4
Theofilis, P., Tsimihodimos, V., Vordoni, A., et al. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00522-9 · Cited by 4
Aliasghari, F., Izadi, A., Jabbari, M., et al. (2018) · Journal of Medical Biochemistry · doi:10.1515/jomb-2018-0006 · Cited by 4
Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial
Dhar, M., Mittal, K., Parchani, A., Sharma, M., Bahurupi, Y. A., Kalra, S., & Bhat, N. K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056994 · Cited by 5
Could the PON1 phenotype play a key role in insulin resistance?
Sarıkaya, U., Meydan, S., Selek, Ş., Sarıkaya, A., Demirel, M., Gül, A. Z., & Yıldız, T. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01096-x · Cited by 4
Ma, C., Lu, N., Kong, F.-S., et al. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0087 · Cited by 4
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects
ARGÜELLES-TELLO, F. A., Kammar‐García, A., Trejo-Jasso, C., Huerta‐Cruz, J. C., Barranco‐Garduño, L. M., Rocha-González, H. I., & Reyes‐García, G. (2022) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp204180 · Cited by 4
Sanctis, V. D., Daar, S., Soliman, A. T., Tzoulis, P., Yassin, M. A., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v93i3.12825 · Cited by 5
Cardiovascular risk markers in premature canities
Das, S., Chander, R., Garg, T., Mendiratta, V., Singh, R., & Sanke, S. (2022) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_501_2021 · Cited by 4
Kufe, C. N., Goedecke, J. H., Masemola, M., Chikowore, T., Soboyisi, M., Smith, A., Westgate, K. L., Brage, S., & Micklesfield, L. K. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002815 · Cited by 6
Razouki, Z. A., Zhang, X., Hwang, J. P., & Heredia, N. I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154260 · Cited by 4
Tzeng, H.-P., Chiu, C., Liu, S., & Chiang, M. (2022) · Metabolites · doi:10.3390/metabo12080693 · Cited by 4
Satomura, A., Oikawa, Y., Sato, H., Takagi, S., Yamashita, T., & Shimada, A. (2022) · Diabetology International · doi:10.1007/s13340-022-00599-6 · Cited by 5
Soetikno, V., Murwantara, A., Jusuf, A. A., et al. (2022) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-022-00275-3 · Cited by 4
Stenkula, K. G., Klemendz, L. E., Fryklund, C., Wierup, N., Alsalim, W., Landin‐Olsson, M., Trinh, L., Månsson, S., & Bennet, L. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01679-x · Cited by 4
Ferreira, P. P. R., Silva, L. F. R., Dias‐Peixoto, M. F., Cassilhas, R. C., Gripp, F., Amorim, F. T., Mang, Z. A., Esteves, E. A., Tricoli, V., Ferraresi, C., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100984 · Cited by 4
Association between depressive symptoms and pericardial fat in healthy older men and women
Miller, N. E., & Steptoe, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-17888-4 · Cited by 4
Onslow, M., Wolsk, J., Wisniewski, S. R., Patel, S. R., Gallaher, M. J., Hubel, C. A., Cashmere, D. J., & Facco, F. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10254 · Cited by 4
Korpijaakko, C. A., Eriksson, M. D., Wasenius, N., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01612-7 · Cited by 4
Okura, T., Nakamura, R., Ito, Y., Kitao, S., Anno, M., Endo, S., Taneda, N., Matsumoto, K., Shoji, K., Okura, H., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002908 · Cited by 5
Mendham, A. E., Micklesfield, L. K., Karpe, F., Kengne, A. P., Chikowore, T., Kufe, C. N., Masemola, M., Crowther, N. J., Norris, S. A., Olsson, T., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05788-1 · Cited by 4
ALrefai, A. A., Elsalamony, E. M., Fatani, S. H., et al. (2022) · Biochemistry Research International · doi:10.1155/2022/6097864 · Cited by 4
Alzubaidi, Z. F., Khodair, B. A. W., Mohammed, N. I., & Mohammed, T. K. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9754 · Cited by 4
Li, Y., Wu, M., Lee, W., et al. (2022) · Biomolecules · doi:10.3390/biom12101408 · Cited by 4
Repke, H. E., Gulley, L. D., Rice, A. J., Gallagher-Teske, J. H., Markos, B., Sánchez, N., Bristol, M., Haynes, H. E., Lavender, J. M., Neyland, M. K. H., et al. (2022) · Nutrients · doi:10.3390/nu14204246 · Cited by 5
Jo, S., Harris, W. S., Tintle, N., & Park, Y. (2022) · Nutrients · doi:10.3390/nu14204407 · Cited by 4
Kyohara, M., Miyashita, D., Inoue, R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276915 · Cited by 4
Costa, R. O., Medeiros, I., de Queiroz, J. L. C., et al. (2022) · Foods · doi:10.3390/foods11213526 · Cited by 4
Khodarahmi, M., Siri, G., Mohammadi, M., Farhangi, M. A., & Alesaeidi, . (2022) · BioMed Research International · doi:10.1155/2022/3044545 · Cited by 4
Fernández-López, M., Blanco‐Carnero, J. E., Guardia-Baena, J. M., Matallana, C. D. P., Alonso, A. A., & Hernández-Martínez, A. M. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002915 · Cited by 4
Miller‐Kasprzak, E., Musialik, K., Kręgielska-Narożna, M., Szulińska, M., & Bogdański, P. (2022) · Nutrients · doi:10.3390/nu14235092 · Cited by 4
Widmer, A., Mercante, M. G., & Silver, H. J. (2022) · Nutrients · doi:10.3390/nu14235106 · Cited by 4
Bengtson, A. M., Pellowski, J. A., McGarvey, S. T., McGinty, R., Botha, M., Burd, T., Burgner, D. P., Mansell, T., & Zar, H. J. (2022) · AIDS · doi:10.1097/qad.0000000000003412 · Cited by 4
Mariné-Casadó, R., Domenech-Coca, C., Crescenti, A., Rodriguez, M. A., Bas-Prior, J. M. D., Arola, L., Boqué, N., & Caimari, A. (2022) · Nutrients · doi:10.3390/nu14235134 · Cited by 4
Alfaro‐Lara, V., Múñoz‐Hernández, R., Giménez, L., Beltrán, L. M., Castell‐Montsalve, F. J., & Stiefel, P. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14600 · Cited by 4
HIV and race are independently associated with endothelial dysfunction
Mouchati, C., Durieux, J., Zisis, S. N., & McComsey, G. A. (2022) · AIDS · doi:10.1097/qad.0000000000003421 · Cited by 4
Fosam, A. E., Bansal, R., Ramanathan, A. L., Sarcone, C., Iyer, I., Murthy, M., Remaley, A. T., & Muniyappa, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac189 · Cited by 4
Suárez‐Ortegón, M. F., Arbeláez, A., Moreno‐Navarrete, J. M., Ortega, J. G., Mosquera, M., & Fernández‐Real, J. M. (2022) · Antioxidants · doi:10.3390/antiox12010019 · Cited by 4
Polak-Szczybyło, E., Stępień, A. E., Zielińska, M., & Dąbrowski, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010056 · Cited by 4
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
